VCEL Q1 2023 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$41M+13.7% YoY

Gross Profit

$27M64.7% margin

Operating Income

-$8M-19.9% margin

Net Income

-$7M-18.3% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

-22.2%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

-$1M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$265M

Total Liabilities

$71M

Stockholders' Equity

$194M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$36M	+13.7%
Gross Profit	$27M	$23M	+13.1%
Operating Income	-$8M	-$7M	-12.4%
Net Income	-$7M	-$7M	-5.7%

Revenue Segments

MACI Implants And Kits

$34M100%